Sunscreens: A review of health benefits, regulations, and controversies

Dermatologic Clinics

Volumn 32, Issue 3, 2014, Pages 427-438

  Mancebo, Silvia E ^a   Hu, Judy Y ^b   Wang, Steven Q ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Global Health Research LLC   (United States)

Author keywords

Photoprotection; Skin cancer prevention; Sunscreen controversies; Sunscreen regulations

Indexed keywords

OXYBENZONE; SUNSCREEN; TITANIUM DIOXIDE NANOPARTICLE; ZINC OXIDE NANOPARTICLE;

ACTINIC KERATOSIS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG APPROVAL; DRUG EFFICACY; DRUG LABELING; DRUG LEGISLATION; DRUG SAFETY; DRUG USE; HEALTH CARE DELIVERY; HUMAN; MELANOMA; PATIENT COMPLIANCE; PHOTOAGING; PHOTODERMATOSIS; PRIORITY JOURNAL; REVIEW; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; VITAMIN D DEFICIENCY; ADVERSE EFFECTS; HEALTH STATUS; SKIN NEOPLASMS; ULTRAVIOLET RADIATION;

HEALTH STATUS; HUMANS; SKIN NEOPLASMS; SUNSCREENING AGENTS; TREATMENT OUTCOME; ULTRAVIOLET RAYS;

EID: 84901608346     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2014.03.011     Document Type: Review

References (82)

1. Rogers H.W., Weinstock M.A., Harris A.R., et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010, 146(3):283-287.
2. Robinson J.K. Sun exposure, sun protection, and vitamin D. JAMA 2005, 294(12):1541-1543.
3. International Agency for Research on Cancer Solar and ultraviolet radiation 1992, International Agency for Research on Cancer, Lyon (France).
4. Sayre R.M., Dowdy J.C., Lott D.L., et al. Commentary on 'UVB-SPF': the SPF labels of sunscreen products convey more than just UVB protection. Photodermatol Photoimmunol Photomed 2008, 24(4):218-220.
5. Armstrong B.K., Kricker A. How much melanoma is caused by sun exposure?. Melanoma Res 1993, 3(6):395-401.
6. Coblentz W.W. The Copenhagen Meeting of the Second International Congress on Light. Science 1932, 76(1975):412-415.
7. Kullavanijaya P., Lim H.W. Photoprotection. J Am Acad Dermatol 2005, 52(6):937-958. [quiz: 959-62].
8. Calzavara-Pinton P., Sala R., Arisi M.C., et al. Photobiology, photodermatology and sunscreens: a comprehensive overview. Part 1: damage from acute and chronic solar exposure. G Ital Dermatol Venereol 2013, 148(1):89-106.
9. Marrot L., Meunier J.R. Skin DNA photodamage and its biological consequences. J Am Acad Dermatol 2008, 58(5 Suppl 2):S139-S148.
10. Budden T., Bowden N.A. The role of altered nucleotide excision repair and UVB-induced DNA damage in melanomagenesis. Int J Mol Sci 2013, 14(1):1132-1151.
11. Ravanat J.L., Douki T., Cadet J. Direct and indirect effects of UV radiation on DNA and its components. J Photochem Photobiol B 2001, 63(1-3):88-102.
12. Djavaheri-Mergny M., Mergny J.L., Bertrand F., et al. Ultraviolet-A induces activation of AP-1 in cultured human keratinocytes. FEBS Lett 1996, 384(1):92-96.
13. Darr D., Fridovich I. Free radicals in cutaneous biology. J Invest Dermatol 1994, 102(5):671-675.
14. Runger T.M., Kappes U.P. Mechanisms of mutation formation with long-wave ultraviolet light (UVA). Photodermatol Photoimmunol Photomed 2008, 24(1):2-10.
15. Moyal D., Fourtanier A. Acute and chronic effects of UV on skin. Photoaging 2004, 15-32. Marcel Dekker, Inc, New York. D.S. Rigel, R.A. Weiss, H.W. Lim (Eds.).
16. Gil E.M., Kim T.H. UV-induced immune suppression and sunscreen. Photodermatol Photoimmunol Photomed 2000, 16(3):101-110.
17. Sklar L.R., Almutawa F., Lim H.W., et al. Effects of ultraviolet radiation, visible light, and infrared radiation on erythema and pigmentation: a review. Photochem Photobiol Sci 2013, 12(1):54-64.
18. National Cancer Institute. Sun protection. Cancer trends progress report 2011/2012 Update. 2012. Available at:. Accessed July 31, 2013. http://progressreport.cancer.gov/doc_detail.asp?pid=1%26did=2009%26chid=91%26coid=911%26mid=#trends.
19. Gantz G.M., Sumner W.G. Stable ultraviolet light absorbers. Textile Res J 1957, 27:244-251.
20. Knox J.M., Guin J., Cockerell E.G. Benzophenones. Ultraviolet light absorbing agents1. J Invest Dermatol 1957, 29(6):435-444.
21. Kanof N.H. Protection of the skin against the harmful effects of sunlight. Arch Dermatol Res 1956, 74:46.
22. Celleno L., Calzavara-Pinton P., Sala R., et al. Photobiology, photodermatology and sunscreens: a comprehensive overview. Part 2: topical and systemic photoprotection. G Ital Dermatol Venereol 2013, 148(1):107-133.
23. Kockler J., Robertson S., Oelgemöller M., et al. Butyl methoxy dibenzoylmethane. Profiles of drug substances, excipients, and related methodology 2013, 38(2013):87-111.
24. Deflandre A., Lang G. Photostability assessment of sunscreens. Benzylidene camphor and dibenzoylmethane derivatives. Int J Cosmet Sci 1988, 10(2):53-62.
25. Beasley D., Meyer T. Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen products. Am J Clin Dermatol 2010, 11(6):413-421.
26. Bonda C. The photostability of organic sunscreen actives: a review. Sunscreens: regulations and commercial development 2005, 321-349. Taylor & Francis, Boca Raton (FL). 3rd edition. N. Shaath (Ed.).
27. Wang S.Q., Balagula Y., Osterwalder U. Photoprotection: a review of the current and future technologies. Dermatol Ther 2010, 23(1):31-47.
28. Mitchnick M.A., Fairhurst D., Pinnell S.R. Microfine zinc oxide (Z-cote) as a photostable UVA/UVB sunblock agent. J Am Acad Dermatol 1999, 40(1):85-90.
29. Chen L., Tooley I., Wang S. Nanotechnology in photoprotection. Nanotechnology in dermatology 2013, 9-18. Springer, New York. A. Nasir, A. Friedman, S. Wang (Eds.).
30. Wang S.Q., Tooley I.R. Photoprotection in the era of nanotechnology. Semin Cutan Med Surg 2011, 30(4):210-213.
31. Darlington S., Williams G., Neale R., et al. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003, 139(4):451-455.
32. van der Pols J.C., Williams G.M., Pandeya N., et al. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006, 15(12):2546-2548.
33. Green A.C., Williams G.M., Logan V., et al. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011, 29(3):257-263.
34. Hughes M.C., Williams G.M., Baker P., et al. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med 2013, 158(11):781-790.
35. Bissonnette R., Nigen S., Bolduc C. Influence of the quantity of sunscreen applied on the ability to protect against ultraviolet-induced polymorphous light eruption. Photodermatol Photoimmunol Photomed 2012, 28(5):240-243.
36. Green A., Williams G., Neale R., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999, 354(9180):723-729.
37. Chesnut C., Kim J. Is there truly no benefit with sunscreen use and Basal cell carcinoma? A critical review of the literature and the application of new sunscreen labeling rules to real-world sunscreen practices. J Skin Cancer 2012, 2012:480985.
38. Criscione V.D., Weinstock M.A., Naylor M.F., et al. Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 2009, 115(11):2523-2530.
39. Thompson S.C., Jolley D., Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993, 329(16):1147-1151.
40. Green A.C., McBride P. Squamous cell carcinoma of the skin (non-metastatic). Clin Evid (Online) 2010, 2010:1-8.
41. de Gruijl F.R. Photobiology of photocarcinogenesis. Photochem Photobiol 1996, 63(4):372-375.
42. Green A.C., Williams G.M. Point: sunscreen use is a safe and effective approach to skin cancer prevention. Cancer Epidemiol Biomarkers Prev 2007, 16(10):1921-1922.
43. Situm M., Buljan M., Bulat V., et al. The role of UV radiation in the development of basal cell carcinoma. Coll Antropol 2008, 32(Suppl 2):167-170.
44. Dennis L.K., Vanbeek M.J., Beane Freeman L.E., et al. Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Ann Epidemiol 2008, 18(8):614-627.
45. Berwick M. Counterpoint: sunscreen use is a safe and effective approach to skin cancer prevention. Cancer Epidemiol Biomarkers Prev 2007, 16(10):1923-1924.
46. Dennis L.K., Beane Freeman L.E., VanBeek M.J. Sunscreen use and the risk for melanoma: a quantitative review. Ann Intern Med 2003, 139(12):966-978.
47. Green A.C., Hughes M.C., McBride P., et al. Factors associated with premature skin aging (photoaging) before the age of 55: a population-based study. Dermatology 2011, 222(1):74-80.
48. Holman C.D., Armstrong B.K., Evans P.R., et al. Relationship of solar keratosis and history of skin cancer to objective measures of actinic skin damage. Br J Dermatol 1984, 110(2):129-138.
49. Kricker A., Armstrong B.K., English D.R., et al. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer-a case-control study. Int J Cancer 1991, 48(5):650-662.
50. Fesq H., Ring J., Abeck D. Management of polymorphous light eruption: clinical course, pathogenesis, diagnosis and intervention. Am J Clin Dermatol 2003, 4(6):399-406.
51. Lenane P., Murphy G.M. Sunscreens and the photodermatoses. J Dermatolog Treat 2001, 12(1):53-57.
52. Schleyer V., Weber O., Yazdi A., et al. Prevention of polymorphic light eruption with a sunscreen of very high protection level against UVB and UVA radiation under standardized photodiagnostic conditions. Acta Derm Venereol 2008, 88(6):555-560.
53. Medeiros V.L., Lim H.W. Sunscreens in the management of photodermatoses. Skin Therapy Lett 2010, 15(6):1-3.
54. Seite S., Reinhold K., Jaenicke T., et al. Broad-spectrum moisturizer effectively prevents molecular reactions to UVA radiation. Cutis 2012, 90(6):321-326.
55. Moyal D. Need for a well-balanced sunscreen to protect human skin from both Ultraviolet A and Ultraviolet B damage. Indian J Dermatol Venereol Leprol 2012, 78(Suppl 1):S24-S30.
56. Wang S.Q., Tanner P.R., Lim H.W., et al. The evolution of sunscreen products in the United States-a 12-year cross sectional study. Photochem Photobiol Sci 2013, 12(1):197-202.
57. U.S. Food and Drug Administration. Final monograph: labeling and effectiveness testing; sunscreen drug products for over-the-counter human use. 2011. Available at:. Accessed September 1, 2013. http://www.gpo.gov/fdsys/pkg/FR-2011-06-17/pdf/2011-14766.pdf.
58. Wang S.Q., Lim H.W. Current status of the sunscreen regulation in the United States: 2011 Food and Drug Administration's final rule on labeling and effectiveness testing. J Am Acad Dermatol 2011, 65(4):863-869.
59. Diffey B.L. Chapter 27 sunscreens: use and misuse. Comprehensive series in photosciences 2001, vol. 3:521-534. Elsevier, Amsterdam.
60. Mease P.J. Spondyloarthritis: is methotrexate effective in psoriatic arthritis?. Nat Rev Rheumatol 2012, 8(5):251-252.
61. U.S. Food and Drug Administration. Sunscreen drug products for over-the- counter human use; request for data and information regarding dosage forms. 2011. Available at:. Accessed September 1, 2013. http://www.gpo.gov/fdsys/pkg/FR-2011-06-17/pdf/2011-14768.pdf.
62. Nakagawa Y., Suzuki T. Metabolism of 2-hydroxy-4-methoxybenzophenone in isolated rat hepatocytes and xenoestrogenic effects of its metabolites on MCF-7 human breast cancer cells. Chem Biol Interact 2002, 139(2):115-128.
63. Ma R., Cotton B., Lichtensteiger W., et al. UV filters with antagonistic action at androgen receptors in the MDA-kb2 cell transcriptional-activation assay. Toxicol Sci 2003, 74(1):43-50.
64. Heneweer M., Muusse M., van den Berg M., et al. Additive estrogenic effects of mixtures of frequently used UV filters on pS2-gene transcription in MCF-7 cells. Toxicol Appl Pharmacol 2005, 208(2):170-177.
65. Schlumpf M., Cotton B., Conscience M., et al. In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect 2001, 109(3):239-244.
66. Wang S.Q., Burnett M.E., Lim H.W. Safety of oxybenzone: putting numbers into perspective. Arch Dermatol 2011, 147(7):865-866.
67. Janjua N.R., Mogensen B., Andersson A.M., et al. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol 2004, 123(1):57-61.
68. Nash J.F. Human safety and efficacy of ultraviolet filters and sunscreen products. Dermatol Clin 2006, 24(1):35-51.
69. Burnett M.E., Wang S.Q. Current sunscreen controversies: a critical review. Photodermatol Photoimmunol Photomed 2011, 27(2):58-67.
70. Nohynek G.J., Lademann J., Ribaud C., et al. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol 2007, 37(3):251-277.
71. Matsuoka L.Y., Ide L., Wortsman J., et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987, 64(6):1165-1168.
72. McLaughlin M., Raggatt P.R., Fairney A., et al. Seasonal variations in serum 25-hydroxycholecalciferol in healthy people. Lancet 1974, 1(7857):536-538.
73. Webb A.R., Kift R., Durkin M.T., et al. The role of sunlight exposure in determining the vitamin D status of the U.K. white adult population. Br J Dermatol 2010, 163(5):1050-1055.
74. Webb A.R., Pilbeam C., Hanafin N., et al. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 1990, 51(6):1075-1081.
75. Halpern A.C. Vitamin D: a clinical perspective. Pigment Cell Melanoma Res 2013, 26(1):5-8.
76. Rosen C.J., Abrams S.A., Aloia J.F., et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 2012, 97(4):1146-1152.
77. Wang S.Q., Hu J.Y. Challenges in making effective sunscreen. The melanoma letter 2012, vol. 30:4-6. Skin Cancer Foundation, New York. A.C. Halpern, A.A. Marghoob (Eds.).
78. Autier P., Dore J.F., Negrier S., et al. Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J Natl Cancer Inst 1999, 91(15):1304-1309.
79. Autier P., Dore J.F., Reis A.C., et al. Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double blind randomized trial using personal dosimeters. Br J Cancer 2000, 83(9):1243-1248.
80. Autier P. Sunscreen abuse for intentional sun exposure. Br J Dermatol 2009, 161(Suppl 3):40-45.
81. Autier P., Boniol M., Severi G., et al. Quantity of sunscreen used by European students. Br J Dermatol 2001, 144(2):288-291.
82. Thieden E., Philipsen P.A., Sandby-Moller J., et al. Sunscreen use related to UV exposure, age, sex, and occupation based on personal dosimeter readings and sun-exposure behavior diaries. Arch Dermatol 2005, 141(8):967-973.